Postbiotics Market Size Worth USD 310.66 Million by 2034 | CAGR: 8.85%

The postbiotics market size is expected to reach USD 310.66 Million by 2034, according to a new study by Polaris Market Research. The report “Postbiotics Market Size, Share, Trends, Industry Analysis Report By Form (Powder, Capsules, Liquid, Tablets, and Others), By Type, By Distribution Channel, and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Postbiotics are emerging as functional ingredients in preventive healthcare and nutrition, offering scientifically validated benefits such as improved gut health, enhanced immune modulation, and metabolic support without the viability challenges associated with probiotics.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/postbiotics-market/request-for-sample

The market is growing significantly due to the rising consumer demand for safe, stable, and sustainable health solutions, increasing application in dietary supplements, functional foods, and pharmaceuticals, and continuous innovations that improve formulation flexibility and regulatory compliance.

Postbiotics Market Report Highlights

• Based on form, the powder segment dominated the market in 2024, due to its stability, ease of formulation, and high compatibility with functional foods, beverages, and dietary supplements.
• Based on type, short-chain fatty acids (SCFAs) held the largest share in 2024, owing to clinically validated role in maintaining gut health, regulating metabolism, and reducing inflammation.
• In terms of distribution channel, online retail accounted for a significant share in 2024, fueled by the growing preference for e-commerce platforms offering a wide range of health products, subscription models, and home delivery convenience.
• Asia Pacific accounted for a dominant share in 2024, supported by rising health and wellness awareness across China, India, and Southeast Asia.
• North America is projected to grow at the fastest CAGR, attributed to strong consumer demand for functional foods and dietary supplements targeting digestive health and immune support.
• Key players in the global market include Archer-Daniels-Midland Company, BASF SE, Beekeeper's Naturals, Inc., Bioflag Group, Cargill, Incorporated, DSM-Firmenich AG, Essential Formulas Incorporated, Glac Biotech Co., Ltd., Ildong Pharmaceutical Co., Ltd., Kerry Group plc, Kemin Industries, Inc., MCLS Europe B.V., Phileo by Lesaffre, Sabinsa Corporation, and POSTBIOTICA S.R.L.

Polaris Market Research has segmented the market report based on form, type, distribution channel, and region:

By Form Outlook (Revenue, USD Million, 2020–2034)

• Powder
• Capsules
• Liquid
• Tablets
• Others

By Type Outlook (Revenue, USD Million, 2020–2034)

• Short-chain fatty acids
• Lipopolysaccharides
• Muramly dipeptide
• Indole
• Teichoic acid
• Lactose Pin
• P40 molecule

By Distribution Channel Outlook (Revenue, USD Million, 2020–2034)

• Online Retail
• Supermarkets/Hypermarkets
• Drug Stores
• Retail Stores
• Convenience Store
• Others

By Regional Outlook (Revenue, USD Million, 2020–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America